- Mismatched Imaging Findings of Prostate Cancer Diagnosis: 68 Ga-PSMA PET/CT vs mpMRI
-
Lopci E, Colombo P, Lazzeri M
- KMID: 2519274
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):199-202.
- doi: 10.1007/s13139-021-00701-x
Multiparametric magnetic resonance imaging (mpMRI) is the modality of choice for initial diagnosis of prostate cancer (PCa), including biopsy-naïve patients. Nevertheless, clinicians must be aware of the possibility that up... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature
-
Abrate A, Lughezzani G, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta , Buffi N, Guazzoni G, Lazzeri M
- KMID: 1794571
- Korean J Urol.
- 2014 Jul;55(7):436-445.
- doi: 10.4111/kju.2014.55.7.436
Prostate-specific antigen (PSA) is recognized as an organ-specific marker with low specificity and sensitivity in discriminating prostate cancer (PCa) from other benign conditions, such as prostatic hyperplasia or chronic prostatitis.... -
- CITED
-
- Close
- SHARE
-
- Close
